OIG Is Scrutinizing Whether Part D Discounts Are Passed On To Enrollees

The issue of whether Medicare drug plan enrollees see pocketbook savings as a result of Part D drug price concessions is under HHS Office of Inspector General evaluation in a series of ongoing reviews slated for completion in 2008 as well as a newly initiated study